• 1
    Kerbel RS. Significance of tumor-host interactions in cancer growth and metastases. Cancer Metastasis Rev 1995; 14: 25962.
  • 2
    Clark EA,Golub TR,Lander ES,Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000; 406: 5325.
  • 3
    Jurasz P,Alonso-Escolano D,Radomski MW. Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 2004; 143: 81926.
  • 4
    Nieswandt B,Hafner M,Echtenacher B,Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999; 59: 1295300.
  • 5
    Kato Y,Fujita N,Yano H,Tsuruo T. Suppression of experimental lung colonization of mouse colon adenocarcinoma 26 in vivo by an anti-idiotype monoclonal antibody recognizing a platelet surface molecule. Cancer Res 1997; 57: 30405.
  • 6
    Pearlstein E,Ambrogio C,Karpatkin S. Effect of Antiplatelet Antibody on the Development of Pulmonary Metastases Following Injection of Ct26 Colon Adenocarcinoma, Lewis Lung-Carcinoma, and B-16 Amelanotic Melanoma Tumor-Cells in Mice. Cancer Res 1984; 44: 38847.
  • 7
    Palumbo JS,Talmage KE,Massari JV,La Jeunesse CM,Flick MJ,Kombrinck KW,Jirouskova M,Degen JL. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 2005; 105: 17885.
  • 8
    Honn KV,Cicone B,Skoff A. Prostacyclin—a Potent Anti-Metastatic Agent. Science 1981; 212: 12702.
  • 9
    Amirkhosravi A,Mousa SA,Amaya M,Blaydes S,Desai H,Meyer T,Francis JL. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 2003; 90: 54954.
  • 10
    Trikha M,Zhou Z,Timar J,Raso E,Kennel M,Emmell E,Nakada MT. Multiple roles for platelet GPIIb/IIIa and alpha v beta 3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res 2002; 62: 282433.
  • 11
    Burdick MM,Konstantopoulos K. Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow. Am J Physiol-Cell Physiol 2004; 287: C53947.
  • 12
    Im JH,Fu W,Wang H,Bhatia SK,Hammer DA,Anna Kowalska M,Muschel RJ. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 2004; 64: 861319.
  • 13
    Borsig L,Wong R,Feramisco J,Nadeau DR,Varki NM,Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 2001; 98: 33527.
  • 14
    Rabenstein DL. Heparin and heparan sulfate: structure and function. Nat Prod Rep 2002; 19: 31231.
  • 15
    Lapierre F,Holme K,Lam L,Tressler RJ,Storm N,Wee J,Stack RJ,Castellot J,Tyrrell DJ. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology 1996; 6: 35566.
  • 16
    Wang JG,Mu JS,Zhu HS,Geng JG. N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury invivo. Inflamm Res 2002; 51: 43543.
  • 17
    Wei M,Tai GH,Gao YG,Na Li,BaiquHuang,YifaZhou,ShuiHao,XianluZeng. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow. J Biol Chem 2004; 279: 2920210.
  • 18
    Mekrache M,Legendre P,Kieffer N,Baruch D. Activation of integrin alpha IIb beta 3 expressed in Chinese hamster ovary cells is required for interaction with solid-phase von Willebrand factor. Br J Haematol 2002; 119: 102432.
  • 19
    Ludwig RJ,Boehme B,Podda M,Henschler R,Jager E,Tandi C,Boehncke WH,Zollner TM,Kaufmann R,Gille J. Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis. Cancer res 2004; 64: 27432750.
  • 20
    McCarty OJ,Mousa SA,Bray PF,Konstantopoulos K. Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 2000; 96: 178997.
  • 21
    Salsmann A,Schaffner-Reckinger E,Kabile F,Plancon S,Kieffer N. A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin alpha IIb beta 3-dependent RhoA activation during cell spreading. J Biol Chem 2005; 280: 336109.
  • 22
    Legendre P,Salsmann A,Rayes J,Trassard O,Kieffer N,Baruch D. CHO cells expressing the high affinity alpha(IIb)beta(3)T562N integrin demonstrate enhanced adhesion under shear. J Thromb Haemost 2006; 4: 23646.
  • 23
    Saalbach A,Wetzel A,Haustein UF,Sticherling M,Simon JC,Anderegg U. Interaction of human Thy-1 (CD 90) with the integrin alpha v beta 3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium. Oncogene 2005; 24: 471020.
  • 24
    Sobel M,Fish WR,Toma N,Luo S,Bird K,Mori K,Kusumoto S,Blystone SD,Suda Y. Heparin modulates integrin function in human platelets. J Vasc Surg 2001; 33: 58794.
  • 25
    Amirkhosravi A,Amaya M,Siddiqui F,Biggerstaff JP,Meyer TV,Francis JL. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis. Platelets 1999; 10: 28592.
  • 26
    Jackson SP. The growing complexity of platelet aggregation. Blood 2007; 109: 508795.
  • 27
    Ma YQ,Geng JG. Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow. J Immunol 2000; 165: 55865.
  • 28
    Stone JP,Wagner DD. P-selectin mediates adhesion of platelets to neuroblastoma and small-cell lung-cancer. J Clin Invest 1993; 92: 80413.
  • 29
    Mannori G,Crottet P,Cecconi O,Hanasaki K,Aruffo A,Nelson RM,Varki A,Bevilacqua MP. Differential colon-cancer cell-adhesion to E-selectin, P-Selectin and L-selectin - role of mucintype glycoproteins. Cancer Res 1995; 55: 442531.
  • 30
    Rand ML,Wang H,Mody M,Chu I,Treutiger I,Nguyen A,Packham MA,Freedman J. Concurrent measurement of the survival of two populations of rabbit platelets labeled with either two PKH lipophilic dyes or two concentrations of biotin. Cytometry 2002; 47: 11117.
  • 31
    Karpatkin S,Pearlstein E. Role of platelets in tumor-cell metastases. Ann Intern Med 1981; 95: 63641.
  • 32
    Gasic GJ. Role of plasma, platelets and endothelial-cells in tumor-metastasis. Cancer Metastasis Rev 1984; 3: 99114.
  • 33
    Handa K,White T,Ito K,Fang H,Wang SS,Hakomori SI. P-selectin-dependent adhesion of human cancer-cells-requirement for coexpression of a Psgl-1-like core protein and the glycosylation process for sialosyl-Le(X) or sialosyl-Le(a). Int J Oncol 1995; 6: 77381.
  • 34
    Dardik R,Savion N,Kaufmann Y,Varon D. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer 1998; 77: 206975.
  • 35
    Gao YG,Wei M,Zheng S,Ba XQ,Hao S,Zeng XL. Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin. J Cancer Res Clin Oncol 2006; 132: 25764.
  • 36
    Salmivirta M,Safaiyan F,Prydz K,Andresen MS,Aryan M,Kolset SO. Differentiation-associated modulation of heparan sulfate structure and function in CaCo-2 colon carcinoma cells. Glycobiology 1998; 8: 102936.
  • 37
    Engelberg H. Actions of heparin that may affect the malignant process. Cancer 1999; 85: 25772.
  • 38
    Nash GF,Turner LF,Scully MF,Kakkar AK. Platelets and cancer. Lancet Oncol 2002; 3: 42530.
  • 39
    Quinn MJ,Byzova TV,Qin J,Topol EJ,Plow EF. Integrin alpha(IIb)beta(3) and its antagonism. Arterioscler Thromb Vasc Biol 2003; 23: 94552.
  • 40
    Park K,Ki Lee S,Hyun Son D,Ah Park S,Kim K,Won Chang H,Jeong EJ,Park RW,Kim IS,Chan Kwon I,Byun Y,Kim SY. The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative. Biomaterials 2007; 28: 266776.
  • 41
    Niers.TM,Klerk.CP,DiNisio.M,Van Noorden.CJ,Büller.HR,Reitsma.PH,Richel.DJ. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Oncol Hematology 2007; 61: 195207.